As adenoma and inflammatory bowel disease (ulcerative colitis and Crohn`s disease) are well-accepted risk factors for CRC development [23, 24], we found increasing trend of PRM1 expression in colorectal adenoma and cancer tissues, and it is worthy to further investigate whether PRM1 can be used as an alarm marker for CRC. This evidence concerns the gene PRM1 and Crohn disease.